BridgeMD
New treatment option for Lateral Epicondylitis
Official title Multimodal Rehabilitation Approach in Patients of Lateral Epicondylitis
ClinicalTrials.gov ID: NCT06686732
What this study is testing
- What it's testing
- Literature is scarce for high quality evidence regarding multimodal rehabilitation in lateral epicondylitis. By making comparisons with the conventional treatment of patients with lateral epicondylitis, the current study aims to further establish the efficacy of the multimodal rehabilitation protocol through a RCT in order to generalize the results, using dynamometer as an additional tool for pre and post assessments against the outcome measures.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45
You may be able to join if
- Point tenderness at the lateral epicondyle
- Positive Cozen test, Mill\'s test and Maudsely's test
- Symptoms duration of minimum 2 months
- Consenting to participate in the study
You likely can't join if
- History of fracture in elbow, wrist or hand
- History of surgery in elbow, wrist or hand region
- Elbow conditions other than lateral epicondylitis
- Cognitive deficits and not giving consent
The study team makes the final eligibility decision.
Where it's taking place
- Wāh, Punjab Province, Pakistan
- Islamabad, Pakistan
- Rawalpindi, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wāh, Punjab Province, Pakistan; Islamabad, Pakistan; Rawalpindi, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.